Memogain
| CAS No. | 224169-27-1 | Cat. No. | BCP46887 |
| Name | Memogain | ||
| Synonyms | Benzgalantamine; GLN-1062; GLN-1062; GLN-1062; | ||
| Formula | C24H25NO4 | M. Wt | 391.46 |
| Description | Memogain, also known as GLN-1062, is an acetylcholinesterase (AChE) inhibitor potentially for the treatment of Alzheimer's disease. Memogain, a pro-drug, liberates galantamine on cleavage by a carboxyesterase in the brain. Memogain has more than 15-fold higher bioavailability in the brain than the same doses of galantamine. In the brain, Memogain is enzymatically cleaved to galantamine, thereby regaining its pharmacological activity as a cholinergic enhancer. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | AChE | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.